about
Gene therapy in Parkinson's disease: rationale and current statusAceruloplasminemia With Psychomotor Excitement and Neurological Sign Was Improved by Minocycline (Case Report)The incidence of Parkinsonism in patients with type 1 Gaucher disease: data from the ICGG Gaucher RegistryDefects in very long chain fatty acid synthesis enhance alpha-synuclein toxicity in a yeast model of Parkinson's disease.The link between the GBA gene and parkinsonismMovement disorders induced by antipsychotic drugs: implications of the CATIE schizophrenia trialTranscript expression levels of full-length alpha-synuclein and its three alternatively spliced variants in Parkinson's disease brain regions and in a transgenic mouse model of alpha-synuclein overexpression.Effect of dual-task interference on the hand flexibility of patients with Parkinson's disease carrying the leucine-rich repeat kinase 2 gene mutationThe PARL family of mitochondrial rhomboid proteases.Glucocerebrosidase mutations and the pathogenesis of Parkinson disease.Immune-mediated processes in neurodegeneration: where do we stand?Calcium and Parkinson's disease.Decreased expression of lysosomal alpha-galactosiase A gene in sporadic Parkinson's disease.The L444P GBA mutation is associated with early-onset Parkinson's disease in Mexican Mestizos.Can mesenchymal stem cells reduce vulnerability of dopaminergic neurons in the substantia nigra to oxidative insult in individuals at risk to Parkinson's disease?
P2860
Q22241423-8248B591-7566-433C-B866-E69796693570Q28830683-B22CD08E-8289-4C60-BBD5-0DA258ED5CB6Q33743729-5E19B68D-3E57-4BD7-B95B-B1CD64F3127AQ33802862-B48345D8-BC49-47EA-810D-DFFE561F0781Q34077492-9A82F486-9D3C-4003-B101-ACA3FD0A1A2FQ34480263-C2494C6F-EEA6-460E-8B4C-1BB0E67DB9A3Q35924447-D3C360C8-0829-463C-9D1F-283DEDADF79EQ37313260-9117C1B7-F8BC-474A-9193-F554035090D7Q37666154-9A7E64EA-2EB8-4C00-A214-BE349B6F3BA5Q38161987-63D4596D-6BC9-4B1F-90DB-D4EB502A252AQ38731476-8EFA294B-AAC3-4A29-8A33-0BCA27E27FE4Q38945252-D1F3710A-06D7-4A66-A58A-F404DBF47CA5Q44617144-0625B16D-496F-4105-8D93-D449677EE0D3Q44739431-87FE774B-BF22-4A31-8619-B29D39B1275AQ48615461-81BE24E1-8AE1-4376-8733-C392FD8B702D
P2860
description
2008 nî lūn-bûn
@nan
2008 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Genetic susceptibility in Parkinson's disease
@ast
Genetic susceptibility in Parkinson's disease
@en
type
label
Genetic susceptibility in Parkinson's disease
@ast
Genetic susceptibility in Parkinson's disease
@en
prefLabel
Genetic susceptibility in Parkinson's disease
@ast
Genetic susceptibility in Parkinson's disease
@en
P2860
P1476
Genetic susceptibility in Parkinson's disease
@en
P2093
Jose Miguel Bras
P2860
P304
P356
10.1016/J.BBADIS.2008.11.008
P407
P577
2008-11-20T00:00:00Z